Cerebral
-
‘The Stakes Couldn’t Be Higher’: How DEA’s Proposal Will Affect Telehealth Controlled Substance Prescribing
The DEA recently released proposed rules that would require an in-person visit before a patient can receive a telehealth prescription for a controlled substance. The DEA touts the change as a way to ensure patient safety, but several telehealth advocates argue it will greatly disrupt access for those who need the drugs — especially at a time when the mental health and substance use crisis is growing.
-
Consumer / Employer, Health Tech
Healthcare Moves: A Monthly Summary of Hires and Layoffs
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Cerebral Admits That it Wrongly Shared Data of 3.1M Users
Cerebral recently notified 3.1 million of its users that their private health information was shared with tech companies like Meta, Google and TikTok. The data breach stemmed from Cerebral’s use of pixel tracking technology, which the company said has been discontinued or reconfigured.
-
SoftBank backs mental health app Cerebral, giving it $4.8B valuation
The company recently raised a $300 million funding round led by SoftBank’s second vision fund. It’s one of several digital health startups looking to address access to mental healthcare.